Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 10.770
- +0.230+2.18%
Close Feb 14 16:00 ET
- 11.480
- +0.710+6.59%
Post 20:01 ET
454.49MMarket Cap-3.57P/E (TTM)
10.830High10.485Low236.60KVolume10.600Open10.540Pre Close2.53MTurnover0.73%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High17.80P/B348.28MFloat Cap9.78052wk Low--Dividend TTM32.34MShs Float69.568Historical High--Div YieldTTM3.27%Amplitude4.850Historical Low10.680Avg Price1Lot Size
About UroGen Pharma Ltd Company
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Company Profile
SymbolURGN
Company NameUroGen Pharma Ltd
Listing DateMay 4, 2017
Issue Price13.00
Founded2004
CEOMs. Elizabeth Barrett
MarketNASDAQ
Employees201
Fiscal Year Ends12-31
Address400 Alexander Park Drive,4th floor
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-646-768-9780
Websitehttp://www.urogen.com
Company Executives
- Name
- Position
- Salary
- Elizabeth Barrett
- Director, President and Chief Executive Officer
- 4.64M
- Jason Drew Smith
- General Counsel, Chief Compliance Officer and Corporate Secretary
- 1.51M
- Christopher Degnan
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Mark P. Schoenberg, M.D.
- Chief Medical Officer
- 1.36M
- Dr. Arie S. Belldegrun, F.A.C.S.,M.D.
- Chairman of the Board
- 342.18K
- Dr. Leana S. Wen, M. Sc.,M.D.
- Independent Director
- 194.41K
- James A. Robinson, Jr
- Independent Director
- 313.29K
- Daniel George Wildman
- Independent Director
- 192.72K
- Dr. Stuart Holden, M.D.
- Independent Director
- 201.53K
- Cynthia M. Butitta
- Independent Director
- 204.06K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.